Skip to main content
OpenTrials
Completed

NCT Number: NCT00951262

Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, China

This study aims to develop a life review program and test its effectiveness on a sample of patients with advanced cancer patients receiving palliative care at home in Fuzhou.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

The Fujian Hospice

Fuzhou, Fujian, 350001, China

About this study

A life review program is mainly developed based on Erickson's theory, Confucius's teaching on human development, and the empirical findings of the researcher's preliminary study and pre-pilot study. The program covers reviewing a life for advanced cancer patients and formulating a booklet for them. A randomized controlled trial will be adopted for evaluation of this program. Eligible patients will be randomly assigned to the experimental group and the control group. The subjects in the experimental group will receive a life review program for three weeks. The outcome measure is quality of life (QOL), including domains of physical discomfort, food-related concerns, health care concerns, support, negative emotions, sense of alienation, existential distress and value of life. Subjects' QOL will be assessed before commencement of the program (T0) and one day (T1) and three weeks (T2) after the completion of the program for all subjects in two groups. Perceptions of the program will be elicited within three days after the program for subjects in the experimental group.Descriptive statistics will be used to analyze patients' personal information, disease related information, functional performance and QOL of advanced cancer patients. Repeated measures ANOVA will be used to measure QOL differences in between-group, within-group and interaction effects. Content analysis will be used to analyze the qualitative data collected.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who are newly admitted to the study hospice
  • Patients who are suffering from cancer with metastasis made by a physician
  • Patients who know their diagnosis, prognosis and therapy
  • Patients' functional performance (the score of KPS) at or more than 50%
  • Patients who are adults (≥18 years old)
  • Patients who have no cognitive and verbal communication impairments

Exclusion criteria

  • Patients with planned treatments, such as chemotherapy, radiotherapy or surgery
  • Patients with psychiatric disorders
  • Patients who live outside Fuzhou since the following-up home visit services are not extended to those areas

Treatment and study plan

a life review program

Behavioral

The life review program includes reviewing a life and formalating a life booklet. Reviewing a life consists of three weekly sessions separately addressing illness experience, adulthood life and childhood and adolescence life. Each session lasts about 30 to 60mintues.A booklet with photos documented significant life events will be produced as a gift for the subjects. The edition, photos and contents fo the booklet are determined by the subjects.

Other names: evaluative reminence

Primary outcomes

  1. quality of life

    Time frame: three weeks and six weeks

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Registry information

Official study title

Development and Evaluation of a Life Review Program for Advanced Cancer Patients in Fuzhou, China

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Aug 4, 2009
Registry last updated
Feb 11, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.